The FDA cleared ION-L for skeletally mature patients with DDD from L3 to S1 who have failed conservative care.

Boca Raton, Florida-based SurGenTec designed ION-L to address the demands of posterior lumbar facet fixation while minimizing surgical footprint. Placed bilaterally through a posterior surgical approach, the system spans the facet joint interspace. The company engineered it for controlled, non-impact insertion to protect surrounding patient anatomy. Meanwhile, it reduces the need for extensive posterior exposure.

Key features include a zero-profile implant design and fenestrations and open barrels to support bone graft integration and fusion. Neutral joint positioning capabilities reduce the risk of unintended joint expansion during insertion. Engagement features help resist implant expulsion as well.